Join the SBTDC and guests from Hughes Pittman and Gupton and Hutchison Law on April 4, for a detailed overview of the SBIR / STTR federal R&D funding mechanisms for small businesses, as well as grant accounting practices and legal considerations for your innovation-driven business.  

This session will cover:

The 2023 NCBC Microbiome Symposium will take place in person on Wednesday, May 24, at the North Carolina Biotechnology Center. We have an exciting day of presentations planned, which include keynote speaker Dr. Ken Blount (chief scientific officer at Rebiotix and vice president of microbiome research at Ferring) as well as poster sessions, networking time, and lunch.

This will be an excellent opportunity for researchers to connect with fellow academia and industry scientists. All attendees must register and purchase a ticket using the instructions below.

This webinar will be hosted by the RegenMed Development Organization and Stem Cells Portal with support from the National Science Foundation Advanced Technological Education Program and Bank of America.

With the emergence of regenerative medicine in biomedical research, clinical translation, and scaled biomanufacturing, the foundational science and technology associated with the field is a requisite component of bioscience curricula for community college and baccalaureate bioscience programs.

The Office of Senators Thom Tillis and Ted Budd, the North Carolina Military Business Center, and the North Carolina Biotechnology Center will host the

First Flight Venture Center, a science and technology incubator in Research Triangle Park, won a U.S. Small Business Administration Federal and State Technology Partnership (FAST) Program grant. The FAST program increases the number of competitive grant applications for Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) and impacts grant funding wins by underrepresented companies in NC. 

The Clinical Trials Research Associate curriculum prepares individuals to assist physicians and clinical researchers in the initiation, administration, coordination, and management of clinical research studies for the development of new drugs, clinical products, and treatment regimens. Coursework includes an in-depth study of drug development, Federal regulations, and clinical research processes.

This information session will cover: